North America Artificial Insemination Market - By Type: Sperm Donation, Oocyte Donation; By Application: Livestock Breeding, Human Fertility; By End-user: Hospitals, Fertility Clinics, Veterinary Clinics; By Country: USA and Canada
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 North America Artificial Insemination Market - Opportunity Analysis Index,
By Type,
By Application,
By End-user,
and Region, 2024 - 2031
9. North America North America Artificial Insemination Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Sperm Donation
9.1.2 Oocyte Donation
9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Livestock Breeding
9.2.2 Human Fertility
9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Hospitals
9.3.2 Fertility Clinics
9.3.3 Veterinary Clinics
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 United States
9.4.2 Canada
9.5 North America
North America Artificial Insemination Market – Opportunity Analysis Index,
By Type,
By Application,
By End-user,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America North America Artificial Insemination Market Research Report - Company Profiles
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
10. Competition Landscape
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
10.2.1 Artificial Insemination Market – Genus plc
10.2.2 CRV Holding B.V.
10.2.3 URUS Group LP
10.2.4 Topigs Norsvin
10.2.5 Select Sires Inc.
10.2.6 ABS Global Inc.
10.2.7 Semex
10.2.8 IMV Technologies
10.2.9 Zoetis Inc.
10.2.10 Animal Genetics Inc.
11. Data Collection Method and Research Approach 12. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
